L-GLUTAMIC ACID, N-((((1S)-1-CARBOXY-5-((((4-IODOPHENYL)AMINO)CARBONYL)AMINO)PENTYL)AMINO)CARBONYL)-
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Memorial Sloan Kettering Cancer CenterSmall moleculePhase 1Dormant
CC
42/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 73/ 100
Competitive context
230 Active assets in the Metastatic Castration-Resistant Prostate Cancer (mCRPC) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Darolutamide Bayer | Phase 4 | BBB |
Enzalutamide Prostate Cancer Clinical Trials Consortium | Phase 4 | BBB |
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE Ding-Wei Ye | Phase 4 | BBB |
Darolutamide Bayer | Phase 3 | BB |
Bms-907351 Rana McKay, MD | Phase 3 | BB |
View all 50 →
Same molecule, other indications
L-GLUTAMIC ACID, N-((((1S)-1-CARBOXY-5-((((4-IODOPHENYL)AMINO)CARBONYL)AMINO)PENTYL)AMINO)CARBONYL)- is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →